ADMS
Adamas Pharmaceuticals, Inc.
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
81 hedge funds and large institutions have $273M invested in Adamas Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
-3
Holders Change %
-3.57%
% of All Funds
2.16%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.08%
New
7
Increased
27
Reduced
24
Closed
10
Calls
–
Puts
$358K
Net Calls
-$358K
Net Calls Change
-$26K
Top Buyers
| 1 |
BS
1
Bow Street
New York
|
$18.9M |
| 2 |
GPP
2
Great Point Partners
Greenwich,
Connecticut
|
$42.7M |
| 3 |
3
Millennium Management
New York
|
$11.8M |
| 4 |
BWCA
4
Brenner West Capital Advisors
New York
|
$19.2M |
| 5 |
NC
5
Nexthera Capital
New York
|
$4.57M |
